Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Other Non-Current Liabilities (2021 - 2025)

Core Scientific (CORZW) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $104.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 90.5% to $104.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $104.3 million through Dec 2025, down 90.5% year-over-year, with the annual reading at $104.3 million for FY2025, 90.5% down from the prior year.
  • Other Non-Current Liabilities hit $104.3 million in Q4 2025 for Core Scientific, down from $364.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.2 billion in Q2 2024 to a low of $2.2 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $320.4 million across 5 years, with a median of $99.1 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: surged 8459.25% in 2023 and later crashed 90.86% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $36.9 million in 2021, then crashed by 94.02% to $2.2 million in 2022, then skyrocketed by 4146.74% to $93.9 million in 2023, then skyrocketed by 1069.15% to $1.1 billion in 2024, then tumbled by 90.5% to $104.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CORZW at $104.3 million in Q4 2025, $364.6 million in Q3 2025, and $105.6 million in Q2 2025.